Missing/wrong data?
Log in to edit
COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.
scientific article published in October 2007
Author/s
author: Mario Scartozzi, Rossana Berardi, Stefano Cascinu
Work details
Publication date
October 1, 2007
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.